Pacira BioSciences Presents Cost Reduction Data

Pacira BioSciences will present real-world data on EXPAREL® at the Orthopaedic Research Society's 2026 Annual Meeting. The data highlights EXPAREL's role in reducing the total cost of care for patients undergoing procedures like total knee arthroplasty and spinal fusion. Studies indicate a decrease in healthcare resource utilization, suggesting that EXPAREL can lead to more efficient and cost-effective patient treatment pathways within orthopaedic and spinal surgery.